Document Type : Case Report(s)
Authors
1 Cancer Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
2 Student Research Committee, Mashhad University of Medical Sciences, Mashhad
Abstract
Brain glioblastoma multiforme with leptomeningeal metastasis is a rare medical condition. Although autopsy series have demonstrated a higher incidence of leptomeningeal metastasis, it is usually a late complication in the course of the disease. The disease progression is almost always rapid, resulting in a poor performance status and short survival. There is no single standard treatment but different individualized choices including chemotherapy (standard, anti-angiogenic, intrathecal, immunotherapy), and radiation have been utilized. In this manuscript, we report a male patient with glioblastoma multiforme of left prefrontal lobe that presented with concomitant cervical leptomeningeal metastasis. Because of poor performance, he received hypofractionated radiotherapy of brain and cervical spine which consisted of a total dose of 45 Gy in 10 fractions with 300c Gy per fraction and 30 Gy local boost to the areas of enhancement. Despite this treatment, there was no response and the patient died three days after the completion of the treatment.
Keywords
How to cite this article:
Anvari K, Zarei E, Dehghani M. Primary glioblastoma multiforme with concurrent leptomeningeal metastasis: a case report. Middle East J Cancer. 2023;14(2):343-7. doi: 10.30476/mejc.2022.92906.1669.
- Dehghani M, PeyroShabany B, Shahraini R, Fazilat-Panah D, Hashemi F, Welsh JS, et al. A case report of prostate cancer with leptomeningeal metastasis. Cancer Rep (Hoboken). 2021:e1463. doi: 10.1002/cnr2.1463.
- Yerneni K, Fatemi P, Vogel H, Li G, Zygourakis CC. Leptomeningeal spread with spinal involvement of pineal glioblastoma at initial presentation: A case report. Interdisciplinary Neurosurgery. 2020;21:100658.
- Ng WH, Yeo TT, Kaye AH. Spinal and extracranial metastatic dissemination of malignant glioma. J Clin Neurosci. 2005;12(4):379-82. doi: 10.1016/j.jocn.2004.11.004.
- Akmal S, Ginalis EE, Patel NV, Aiken R, Dicpinigaitis AJ, Hanft SJ. Leptomeningeal disease in glioblastoma: endgame or opportunity? J Neurooncol. 2021;155(2):107-15. doi: 10.1007/s11060-021-03864-x.
- Lardinois B, Miller L, Randazzo A, Laurent T, Debois R, Henry S. Leptomeningeal carcinomatosis: A call for optimizing diagnostic sensitivity by the hematology laboratory. Case Rep Oncol. 2021;14(2):1248-53. doi:10.1159/000518314.
- White MD, Klein RH, Shaw B, Kim A, Subramanian M, Mora JL, et al. Detection of leptomeningeal disease using cell-free DNA from cerebrospinal fluid. JAMA Netw Open. 2021;4(8):e2120040. doi: 10.1001/jamanetworkopen.2021.20040.
- Debnam JM, Mayer RR, Chi TL, Ketonen L, Weinberg JS, Wei W, et al. Most common sites on MRI of intracranial neoplastic leptomeningeal disease. J Clin Neurosci. 2017;45:252-6. doi: 10.1016/j.jocn.2017.07.020.
- Nguyen TK, Myrehaug S, Tseng CL, Husain ZA, Detsky J, Das S, et al. Stereotactic radiotherapy and intracranial leptomeningeal disease. In: Sahgal A, Lo SS, Ma L, Sheehan JP, editors. Image-Guided Hypofractionated Stereotactic Radiosurgery. 2nd ed. Boca Raton: CRC Press; 2021.p. 451-462.
- Pan Z, Yang G, He H, Cui J, Li W, Yuan T, et al. Intrathecal pemetrexed combined with involved-field radiotherapy as a first-line intra-CSF therapy for leptomeningeal metastases from solid tumors: a phase I/II study. Ther Adv Med Oncol. 2020;12:1758835920937953. doi: 10.1177/1758835920937953.
- Buszek SM, Chung C. Radiotherapy in leptomeningeal disease: A systematic review of randomized and nonrandomized trials. Front Oncol. 2019;9:1224. doi:10.3389/fonc.2019.01224.
- Bander ED, Yuan M, Reiner AS, Garton ALA, Panageas KS, Brennan CW, et al. Cerebrospinal fluid diversion for leptomeningeal metastasis: palliative, procedural and oncologic outcomes. J Neurooncol. 2021;154(3):301-13. doi: 10.1007/s11060-021-03827-2.
)